查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552874

植入式给药装置市场规模、份额和趋势分析报告：2024-2030 年按产品、类型、技术、应用、地区和细分市场进行的预测

Implantable Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Type (Biodegradable, Nonbiodegradable), By Technology, By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

植入式给药装置市场成长与趋势：

根据Grand View Research, Inc.的最新报告，到2030年，全球植入式给药装置市场规模预计将达到470.1亿美元，2024年至2030年复合年增长率为8.2%。

慢性病盛行率的增加和对微创治疗方案的需求不断增长正在推动植入式药物传输设备市场的发展。

药物传输技术的最新进展预计将在预测期内推动市场成长。微型植入设备的日益普及也是推动成长的关键因素之一。这些产品可用于改善身体功能、影像和监测药物管理。受控药物输送有利于局部治疗并使治疗剂有针对性地输送到组织。

这些设备有助于克服静脉、口服和局部给药途径的局限性，并拓宽市场的成长前景。此外，生物分解性植入的出现使得将化疗标靶递送至癌细胞而不损害正常细胞成为可能。药物释放植入还可以帮助治疗无法手术的肿瘤，例如肝臟、大脑和肺部的肿瘤。这些设备有助于缩小肿瘤，从而可以透过手术切除肿瘤。这些设备的上述优点预计将在预测期内推动其采用。

新兴市场正致力于开发新型药物输送装置，以占领最大的市场占有率，从而在市场上推出各种技术先进的产品。例如，2017年2月，美国生技公司Delpor, Inc.宣布推出用于长期输送治疗剂的植入式装置。

植入式给药装置市场报告亮点

  • 从产品来看，药物释放型支架将在 2023 年占据市场主导地位，因为它们在荷尔蒙调节、避孕、疼痛管理和癌症治疗中的应用越来越广泛。另一方面，由于周边动脉疾病和冠状动脉疾病的盛行率不断增加，预计生物可吸收支架将出现良好的增长。
  • 按产品类型划分，非生物分解部分在 2023 年占据最大份额。
  • 从技术角度来看，扩散型占据了市场的主导份额，由于患者预后和可接受性的改善，采用率显着增加。
  • 同时，由于多发性硬化症和类风湿性关节炎的盛行率不断上升，预计自体免疫疾病将呈现最快的复合年增长率。
  • 由于慢性病患病率上升、不健康的生活方式和高压力水平，北美在 2023 年占据了相当大的份额，而亚太地区预计到 2025 年将实现较大的复合年增长率。这是由于医疗保健系统的改善、医疗成本的增加和意识的提高。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 植入式给药装置市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 植入式给药装置市场分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 植入式给药装置市场：依产品估计与趋势分析

  • 细分仪表板
  • 植入式给药装置市场：2023 年及 2030 年产品变化分析
  • 避孕植入
  • 脊椎移植
  • 近距离放射治疗种子线
  • 药物释放型支架
  • 生物可吸收支架
  • 眼内植入
  • 点滴帮浦
  • 其他的

第五章 植入式给药装置市场：按类型估计和趋势分析

  • 细分仪表板
  • 植入式给药装置市场：类型变化分析，2023 年和 2030 年
  • 生物分解性
  • 不可生物分解性

第六章 植入式给药装置市场：依技术估算与趋势分析

  • 细分仪表板
  • 植入式给药装置市场：2023 年及 2030 年技术变迁分析
  • 扩散
  • 渗透压
  • 磁的
  • 其他的

第七章 植入式给药装置市场：依应用估计与趋势分析

  • 细分仪表板
  • 植入式给药装置市场：2023 年和 2030 年按应用分类的变化分析
  • 避孕
  • 眼科
  • 心血管
  • 糖尿病
  • 肿瘤学
  • 自体免疫疾病
  • 其他的

第八章植入式给药装置市场：区域估计与趋势分析

  • 2023年及2030年植入式给药装置按地区市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Medtronic
    • Boston Scientific Corporation
    • Allergan
    • Merck &Co., Inc.
    • Bausch and Lomb Incorporated
    • Bayer AG
    • Abbott
    • Teleflex Incorporated
    • Varian Medical Systems, Inc.
简介目录
Product Code: GVR-2-68038-497-0

Implantable Drug Delivery Devices Market Growth & Trends:

The global implantable drug delivery devices market size is expected to reach USD 47.01 billion by 2030, registering to grow at a CAGR of 8.2% from 2024 to 2030 according to a new report by Grand View Research, Inc. The growing incidence of chronic diseases, coupled with rising demand for minimally invasive treatment options, is driving the market for implantable drug delivery devices.

Recent advancements in medication administration technologies are expected to fuel market growth over the forecast period. An increase in the adoption of micro-scale implantable devices is one of the key factors fueling growth. These products find application in monitoring improvement in body functions, imaging, and medication administration. They facilitate localized treatment with controlled drug administration and enable targeted delivery of therapeutics to tissues.

These devices help overcome limitations of intravenous, oral, and topical administration routes, thus broadening the growth prospects of the market. In addition, the advent of biodegradable implants enables the targeted delivery of chemotherapeutics to tumor cells without damaging normal cells. Drug releasing implants are also helpful in the treatment of inoperable tumors such as that of the liver, brain, and lungs, due to their location and size. These devices help in reducing tumor size, which enables the surgical removal of tumors. The aforementioned benefits of these devices are expected to impel their adoption over the forecast period.

Manufacturers are focused on developing novel drug delivery devices to gain maximum market share, which has resulted in the launch of various technologically advanced products in the market. For instance, in February 2017, Delpor, Inc., a biotechnology company in U.S., announced the launch of an implantable device for the long-term delivery of therapeutics.

Implantable Drug Delivery Devices Market Report Highlights:

  • By product, drug-eluting stents held a dominant share in the market in 2023, owing to their growing adoption in hormone regulation, contraception, pain management, and cancer therapy. Bio-absorbable stents, on the other hand, are anticipated to grow at a lucrative rate owing to the increase in incidence of peripheral and coronary artery diseases
  • On the basis of type, the non-biodegradable segment held the largest share in 2023, as a consequence of easy availability of these products and their established efficacy
  • Diffusion held a dominant share in the market on the basis of technology, owing to a significant increase in adoption as it offers better patient outcomes and acceptability
  • Autoimmune diseases, on the other hand, are expected to exhibit the fastest CAGR owing to rising prevalence of multiple sclerosis and rheumatoid arthritis
  • While North America held a substantial share in 2023 owing to the rising prevalence of chronic diseases, unhealthy lifestyles, and high-stress levels among the population, Asia Pacific is anticipated to achieve significant CAGR through 2025. This is owing to improving healthcare systems, rising healthcare expenditure, and growing awareness.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market
  • 1.2. Segmentation and Scope
  • 1.3. Market Definitions
  • 1.4. Research Methodology
    • 1.4.1. Information Procurement
    • 1.4.2. Information or Data Analysis
    • 1.4.3. Market Formulation & Data Visualization
    • 1.4.4. Data Validation & Publishing
  • 1.5. Research Scope and Assumptions
    • 1.5.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Implantable Drug Delivery Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Implantable Drug Delivery Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Implantable Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Implantable Drug Delivery Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Contraceptive Implants
    • 4.3.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Spinal Implants
    • 4.4.1. Spinal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Brachytherapy Seeds
    • 4.5.1. Brachytherapy Seeds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Drug Eluting Stents
    • 4.6.1. Drug Eluting Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Bioabsorbable Stents
    • 4.7.1. Bioabsorbable Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Intraocular Implants
    • 4.8.1. Intraocular Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
  • 4.9. Infusion Pumps
    • 4.9.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 5. Implantable Drug Delivery Devices Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Implantable Drug Delivery Devices Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Biodegradable
    • 5.3.1. Biodegradable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Non-biodegradable
    • 5.4.1. Non-biodegradable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Implantable Drug Delivery Devices Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Implantable Drug Delivery Devices Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Diffusion
    • 6.3.1. Diffusion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Osmotic
    • 6.4.1. Osmotic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Magnetic
    • 6.5.1. Magnetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Implantable Drug Delivery Devices Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Implantable Drug Delivery Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Contraception
    • 7.3.1. Contraception Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Ophthalmology
    • 7.4.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Cardiovascular
    • 7.5.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Diabetes
    • 7.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Oncology
    • 7.7.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Autoimmune Diseases
    • 7.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Others
    • 7.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Implantable Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 8.1. Implantable Drug Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.K.
      • 8.3.2.1. U.K. Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Medtronic
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Boston Scientific Corporation
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Allergan
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Merck & Co., Inc.
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Bausch and Lomb Incorporated
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Bayer AG
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Abbott
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Teleflex Incorporated
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Varian Medical Systems, Inc.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives